European Heart Journal: Cell infusions benefit heart patients

(Cedars-Sinai Medical Center) Three years after the ALLSTAR clinical trial ended prematurely, the study's data shows that treatments of cardiosphere-derived cells -- the same cells used as an experimental therapy tested in COVID-19 patients -- demonstrated unexpected promise in heart attack survivors. Downloadable video available.